Pharmacogenomic Determinants of Post-Liver Transplant Diabetes Mellitus: A Systematic Review and In Silico Pharmacogenomic Analysis
A clinically significant association between genetic variability in tacrolimus metabolism and the development of PTDM following liver transplantation is demonstrated, supporting genotype-guided strategies to optimize immunosuppressive therapy and advance precision medicine in transplant care.